FBTAX
Price
$32.20
Change
+$0.85 (+2.71%)
Updated
Sep 26 closing price
Net Assets
1.46B
PHLQX
Price
$43.84
Change
+$0.89 (+2.07%)
Updated
Sep 26 closing price
Net Assets
1.32B
Interact to see
Advertisement

FBTAX vs PHLQX

Header iconFBTAX vs PHLQX Comparison
Open Charts FBTAX vs PHLQXBanner chart's image
Fidelity Advisor Biotechnology A
Price$32.20
Change+$0.85 (+2.71%)
VolumeN/A
Net Assets1.46B
PGIM Jennison Health Sciences R6
Price$43.84
Change+$0.89 (+2.07%)
VolumeN/A
Net Assets1.32B
FBTAX vs PHLQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. PHLQX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and PHLQX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.46B vs. PHLQX (1.32B). FBTAX pays higher dividends than PHLQX: FBTAX (2.59) vs PHLQX (0.90). FBTAX was incepted earlier than PHLQX: FBTAX (25 years) vs PHLQX (10 years). FBTAX (0.96) is less costly to investors than PHLQX (0.77). PHLQX is a more actively managed with annual turnover of: 79.00 vs. FBTAX (73.00). FBTAX (0) and PHLQX (0) have matching initial minimum investment requirements. FBTAX annual gain was more profitable for investors over the last year : 0.34 vs. PHLQX (-16.35). FBTAX return over 5 years is better than : 6.85 vs. PHLQX (-25.47).
FBTAXPHLQXFBTAX / PHLQX
Total Expense Ratio0.960.77125%
Annual Report Gross Expense Ratio0.960.77125%
Fund Existence25 years10 years-
Gain YTD18.339-0.273-6,718%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B1.32B110%
Annual Yield % from dividends2.590.90289%
Returns for 1 year0.34-16.35-2%
Returns for 3 years43.9017.35253%
Returns for 5 years6.85-25.47-27%
Returns for 10 years50.27N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLFTF3.740.14
+3.89%
RELIEF THERAPEUTICS HLDG AG
ALPMF11.100.10
+0.91%
Astellas Pharma, Inc.
ARTM0.04N/A
N/A
American Nortel Communications, Inc.
CSASF19.89N/A
N/A
Credit Saison Co., Ltd.
SWDCF3.58N/A
N/A
SWEDENCARE AB